The Rochester, Minn.-based Mayo Clinic will share intellectual property with Gentag and perform the research and testing in its facilities. Gentag, which has U.S. headquarters in Washington, D.C., signed a patent-pooling agreement with Mayo, allowing for certain patents and rights to be combined and commercialized, according to a news release. Both parties will collaborate through third parties.
The proposed patch will be a disposable, painless sensor, designed to communicate in a closed-loop diabetes management system that will sync with cell phones. The system also allows for movement tracking, which could aid in addressing obesity, according to the news release.
Mayo’s Micro-Miniature Transceiver chip will be used with Gentag’s radar-responsive tag technology, combining Near Field Communication, Body Area Networks and long-range communication. The goal is to develop an inexpensive, accurate sensor to help treat two growing chronic conditions that cost the U.S. healthcare system significant resources, according to the news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
